A bridge over troubled water-Extending induction for high-risk neuroblastoma patients with poor end-of-induction response

被引：0

作者：

Federico, Sara M. ^{[1
,2
]}

Cash, Thomas ^{[3
,4
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl,Mail Stop 260, Memphis, TN 38105 USA

[2] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Coll Med, Memphis, TN 38163 USA

[3] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA

[4] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA

来源：

CANCER | 2022年 / 128卷 / 15期

关键词：

CHILDRENS ONCOLOGY GROUP; ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; PHASE-II; CHEMOTHERAPY; IRINOTECAN; ANTIBODY; THERAPY; TRIAL;

D O I：

10.1002/cncr.34267

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2880 / 2882

页数：3

共 21 条

[1] The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma [J].

Balis, Frank Milton ;

Busch, Christine Maria ;

Desai, Ami Vijay ;

Hibbitts, Emily ;

Naranjo, Arlene ;

Bagatell, Rochelle ;

Irwin, Meredith ;

Fox, Elizabeth .

PEDIATRIC BLOOD & CANCER, 2020, 67 (01)

[2] To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastoma [J].

Bird, Nicholas ;

Scobie, Nicole ;

Palmer, Antonia ;

Ludwinski, Donna .

PEDIATRIC BLOOD & CANCER, 2022, 69 (08)

[3] Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study [J].

Borowitz, Michael J. ;

Devidas, Meenakshi ;

Hunger, Stephen P. ;

Bowman, W. Paul ;

Carroll, Andrew J. ;

Carroll, William L. ;

Linda, Stephen ;

Martin, Paul L. ;

Pullen, D. Jeanette ;

Viswanatha, David ;

Willman, Cheryl L. ;

Winick, Naomi ;

Camitta, Bruce M. .

BLOOD, 2008, 111 (12) :5477-5485

[4]

Desai AV., 2022, CANCER, V128

[5] Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium [J].

DuBois, Steven G. ;

Granger, M. Meaghan ;

Groshen, Susan ;

Tsao-Wei, Denice ;

Ji, Lingyun ;

Shamirian, Anasheh ;

Czarnecki, Scarlett ;

Goodarzian, Fariba ;

Berkovich, Rachel ;

Shimada, Hiroyuki ;

Villablanca, Judith G. ;

Vo, Kieuhoa T. ;

Pinto, Navin ;

Mosse, Yael P. ;

Maris, John M. ;

Shusterman, Suzanne ;

Cohn, Susan L. ;

Goldsmith, Kelly C. ;

Weiss, Brian ;

Yanik, Gregory A. ;

Twist, Clare J. ;

Irwin, Meredith S. ;

Haas-Kogan, Daphne A. ;

Park, Julie R. ;

Marachelian, Araz ;

Matthay, Katherine K. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (31) :3506-+

[6] A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma [J].

Federico, Sara M. ;

McCarville, M. Beth ;

Shulkin, Barry L. ;

Sondel, Paul M. ;

Hank, Jacquelyn A. ;

Hutson, Paul ;

Meagher, Michael ;

Shafer, Aaron ;

Ng, Catherine Y. ;

Leung, Wing ;

Janssen, William E. ;

Wu, Jianrong ;

Mao, Shenghua ;

Brennan, Rachel C. ;

Santana, Victor M. ;

Pappo, Alberto S. ;

Furman, Wayne L. .

CLINICAL CANCER RESEARCH, 2017, 23 (21) :6441-6449

[7] Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912) [J].

Foster, Jennifer H. ;

Voss, Stephan D. ;

Hall, David C. ;

Minard, Charles G. ;

Balis, Frank M. ;

Wilner, Keith ;

Berg, Stacey L. ;

Fox, Elizabeth ;

Adamson, Peter C. ;

Blaney, Susan M. ;

Weigel, Brenda J. ;

Mosse, Yael P. .

CLINICAL CANCER RESEARCH, 2021, 27 (13) :3543-3548

[8] Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A [J].

Furman, Wayne L. ;

McCarville, Beth ;

Shulkin, Barry L. ;

Davidoff, Andrew ;

Krasin, Matthew ;

Hsu, Chia-Wei ;

Pan, Haitao ;

Wu, Jianrong ;

Brennan, Rachel ;

Bishop, Michael W. ;

Helmig, Sara ;

Stewart, Elizabeth ;

Navid, Fariba ;

Triplett, Brandon ;

Santana, Victor ;

Santiago, Teresa ;

Hank, Jacquelyn A. ;

Gillies, Stephen D. ;

Yu, Alice ;

Sondel, Paul M. ;

Leung, Wing H. ;

Pappo, Alberto ;

Federico, Sara M. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04) :335-+

[9] Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome [J].

Hartlieb, Sabine A. ;

Sieverling, Lina ;

Nadler-Holly, Michal ;

Ziehm, Matthias ;

Toprak, Umut H. ;

Herrmann, Carl ;

Ishaque, Naveed ;

Okonechnikov, Konstantin ;

Gartlgruber, Moritz ;

Park, Young-Gyu ;

Wecht, Elisa Maria ;

Savelyeva, Larissa ;

Henrich, Kai-Oliver ;

Rosswog, Carolina ;

Fischer, Matthias ;

Hero, Barbara ;

Jones, David T. W. ;

Pfaff, Elke ;

Witt, Olaf ;

Pfister, Stefan M. ;

Volckmann, Richard ;

Koster, Jan ;

Kiesel, Katharina ;

Rippe, Karsten ;

Taschner-Mandl, Sabine ;

Ambros, Peter ;

Brors, Benedikt ;

Selbach, Matthias ;

Feuerbach, Lars ;

Westermann, Frank .

NATURE COMMUNICATIONS, 2021, 12 (01)

[10] Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group [J].

Irwin, Meredith S. ;

Naranjo, Arlene ;

Zhang, Fan F. ;

Cohn, Susan L. ;

London, Wendy B. ;

Gastier-Foster, Julie M. ;

Ramirez, Nilsa C. ;

Pfau, Ruthann ;

Reshmi, Shalini ;

Wagner, Elizabeth ;

Nuchtern, Jed ;

Asgharzadeh, Shahab ;

Shimada, Hiroyuki ;

Maris, John M. ;

Bagatell, Rochelle ;

Park, Julie R. ;

Hogarty, Michael D. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (29) :3229-2021

← 1 2 3 →